Encompass Health Corporation
EHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $174,600 | $184,900 | $196,500 | $163,800 |
| Dep. & Amort. | $82,400 | $79,900 | $79,200 | $78,000 |
| Deferred Tax | -$2,100 | -$3,500 | $8,800 | $8,600 |
| Stock-Based Comp. | $14,300 | $14,300 | $9,500 | $12,500 |
| Change in WC | $1,800 | -$3,900 | -$7,500 | $2,800 |
| Other Non-Cash | -$200 | -$1,500 | $2,100 | $13,100 |
| Operating Cash Flow | $270,800 | $270,200 | $288,600 | $278,800 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$187,100 | -$156,900 | -$163,100 | -$198,700 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$38,100 | -$127,800 | $0 | $0 |
| Inv. Sales/Matur. | $28,000 | $121,000 | $11,000 | -$17,900 |
| Other Inv. Act. | -$4,100 | -$1,700 | -$6,400 | $12,900 |
| Investing Cash Flow | -$201,300 | -$165,400 | -$158,500 | -$203,700 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$28,600 | -$22,300 | -$20,000 | -$87,400 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$24,900 | -$24,700 | -$32,100 | -$7,500 |
| Dividends Paid | -$17,000 | -$17,100 | -$18,000 | -$17,000 |
| Other Fin. Act. | -$42,700 | -$26,100 | -$60,300 | -$39,000 |
| Financing Cash Flow | -$113,200 | -$90,200 | -$130,400 | -$150,900 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$43,700 | $14,600 | -$300 | -$75,800 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $137,400 | $122,800 | $123,100 | $198,900 |
| End Cash | $93,700 | $137,400 | $122,800 | $123,100 |
| Free Cash Flow | $83,700 | $113,300 | $125,500 | $80,100 |